Cargando…
A novel approach to minimize the false negative COVID-19 diagnosis by inclusion of specific cell markers and multiple sample collection
The SARS-CoV-2 pandemic has caused unpredictable mortality and economic losses globally. With no approved drug for the treatment, the accurate diagnosis of COVID-19 becomes essential. RNA based test takes several hours and require extensive human intervention for RNA extraction and RT-PCR, but it is...
Autor principal: | Husain, Amjad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881297/ https://www.ncbi.nlm.nih.gov/pubmed/33614422 http://dx.doi.org/10.1016/j.mex.2021.101270 |
Ejemplares similares
-
Blood sample collection in small laboratory animals
por: Parasuraman, S, et al.
Publicado: (2010) -
Beta-binomial modeling of CRISPR pooled screen data identifies target genes with greater sensitivity and fewer false negatives
por: Jeong, Hyun-Hwan, et al.
Publicado: (2019) -
Determinants of DNA yield and purity collected with buccal cell samples
por: van Wieren-de Wijer, D. B. M. A., et al.
Publicado: (2009) -
Detection and correction of false segmental duplications caused by genome mis-assembly
por: Kelley, David R, et al.
Publicado: (2010) -
Allele balance bias identifies systematic genotyping errors and false disease associations
por: Muyas, Francesc, et al.
Publicado: (2018)